Rotate to portrait

Vizual Stocks works best vertically on mobile.

VizualStocks API
PUBLIC DATA DEFINITIONS

Sarepta Therapeutics KPI & segment coverage

Operating KPI and segment definitions available for Sarepta Therapeutics (SRPT) through the VizualStocks API.

SRPT2 metric seriesCatalog checked 2026-10-28
Metric catalog API reference Open in the interactive demo

Active metrics 2

SEGMENT

Elevidys Net Product Revenue

Sarepta net sales of ELEVIDYS, its gene therapy for Duchenne muscular dystrophy. It excludes PMO medicines and separately reported collaboration or licensing revenue from commercial partners.

elevidysNetProductRevenue
Frequency
quarterly / annual
Reported history
Q3'25 — Q2'26
History endpoint
SEGMENT

Pmo Net Product Revenue

Sarepta net sales of its phosphorodiamidate morpholino oligomer exon-skipping medicines EXONDYS 51, VYONDYS 53 and AMONDYS 45 for Duchenne muscular dystrophy. This product-family revenue excludes ELEVIDYS and collaboration or licensing revenue.

pmoNetProductRevenue
Frequency
quarterly / annual
Reported history
Q3'25 — Q2'26
History endpoint